Latest Earnings Results: Q3 '26
Estimated EPS
-$0.50
Reported EPS
-$0.53
Surprise
-6%
Estimated Rev
$6.95M
Reported Rev
$4.81M
Surprise
-30.77%
• Reported GAAP EPS of -$0.53 up 14.52% YoY • Reported revenue of $4.81M up 1073.17% YoY • MeiraGTx estimates cash, receivables, the additional $95M Hologen upfront payment and associated reimbursements will fund operating expenses and capital expenditures into the second half of 2028; this excludes potential Lilly milestones and Royalty Note tranches.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | -$0.49 | -- | -- | N/A |
Q3 '26 | -$0.50 | -$0.53 | -6.00% | MISSED |
Q2 '26 | -$0.46 | $1.71 | 473.09% | BEAT |
Q1 '26 | -$0.61 | -$0.57 | 5.94% | BEAT |
Q4 '25 | -$0.57 | $0.19 | 133.33% | BEAT |